Works matching IS 03065251 AND DT 1992 AND VI 33 AND IP 4
1
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 401, doi. 10.1111/j.1365-2125.1992.tb04058.x
- Scott, AK;
- Grimes, S;
- Ng, K;
- Critchley, M;
- Breckenridge, AM;
- Thomson, C;
- Pilgrim, AJ
- Article
2
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 458, doi. 10.1111/j.1365-2125.1992.tb04069.x
- Leung, NK;
- Bradshaw, CM;
- Szabadi, E
- Article
3
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 411, doi. 10.1111/j.1365-2125.1992.tb04060.x
- Wheeldon, NM;
- McDevitt, DG;
- Lipworth, BJ
- Article
4
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 365, doi. 10.1111/j.1365-2125.1992.tb04053.x
- Article
5
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 439, doi. 10.1111/j.1365-2125.1992.tb04064.x
- Engel, T;
- Scharling, B;
- Skovsted, B;
- Heinig, JH
- Article
6
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 395, doi. 10.1111/j.1365-2125.1992.tb04057.x
- Seymour, RA;
- Weldon, M;
- Kelly, P;
- Nicholson, E;
- Hawkesford, JE
- Article
7
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 454, doi. 10.1111/j.1365-2125.1992.tb04068.x
- Robson, RA;
- Bridgman, PG;
- Wells, JE;
- Bailey, RR;
- Lynn, KL
- Article
8
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 461, doi. 10.1111/j.1365-2125.1992.tb04070.x
- Article
9
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 357, doi. 10.1111/j.1365-2125.1992.tb04052.x
- Article
10
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 449, doi. 10.1111/j.1365-2125.1992.tb04066.x
- Article
11
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 431, doi. 10.1111/j.1365-2125.1992.tb04063.x
- Summers, QA;
- Singh, S;
- Honeywell, RG;
- Renwick, AG;
- Holgate, ST
- Article
12
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 451, doi. 10.1111/j.1365-2125.1992.tb04067.x
- O'Kane, MJ;
- Trinick, TR;
- Tynan, MB;
- Trimble, ER;
- Nicholls, DP
- Article
13
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 423, doi. 10.1111/j.1365-2125.1992.tb04062.x
- Sampson, AP;
- Thomas, RU;
- Costello, JF;
- Piper, PJ
- Article
14
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 377, doi. 10.1111/j.1365-2125.1992.tb04055.x
- Knadler, MP;
- Brater, DC;
- Hall, SD
- Article
15
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 385, doi. 10.1111/j.1365-2125.1992.tb04056.x
- Murray, MD;
- Greene, PK;
- Brater, DC;
- Manatunga, AK;
- Hall, SD
- Article
16
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 405, doi. 10.1111/j.1365-2125.1992.tb04059.x
- Tham, TC;
- Guy, S;
- Shanks, RG;
- Harron, DW
- Article
17
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 417, doi. 10.1111/j.1365-2125.1992.tb04061.x
- Chester, MR;
- Madden, B;
- Barnett, D;
- Yacoub, M
- Article
18
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 369, doi. 10.1111/j.1365-2125.1992.tb04054.x
- Knadler, MP;
- Brater, DC;
- Hall, SD
- Article
19
- British Journal of Clinical Pharmacology, 1992, v. 33, n. 4, p. 445, doi. 10.1111/j.1365-2125.1992.tb04065.x
- Braunstein, G;
- Malaquin, F;
- Fajac, I;
- Melac, M;
- Frossard, N
- Article